cytidine triphosphate has been researched along with B-Cell Lymphoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hiraga, J; Kinoshita, T; Kiyoi, H; Naoe, T; Shimada, K; Sugimoto, T; Tomita, A | 1 |
1 other study(ies) available for cytidine triphosphate and B-Cell Lymphoma
Article | Year |
---|---|
Escape mechanisms from antibody therapy to lymphoma cells: downregulation of CD20 mRNA by recruitment of the HDAC complex and not by DNA methylation.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Azacitidine; Cell Line, Tumor; Cytidine Triphosphate; DNA Methylation; Down-Regulation; Drug Resistance, Neoplasm; Epigenesis, Genetic; Gene Expression Regulation, Leukemic; Histone Deacetylase 1; Humans; Lymphoma, B-Cell; Promoter Regions, Genetic; Repressor Proteins; Rituximab; Sin3 Histone Deacetylase and Corepressor Complex | 2009 |